June 2006

As some pretty costly, yet very useful, drugs are introduced, will new formulary designs deny access to needy patients?

John Carroll

A growing number of health plans are adding these clinics in retail stores to their networks and are realizing savings

Amanda Brower

An exercise in “point-counterpoint” at a recent disease management meeting showed dramatic swings in views

Prepared by the NMHCC Workgroup on Outcomes Assessment in Disease Management

Health plans find themselves paying for the latest and greatest stent without any control over usage. Even bare-metal stents may be overused.

Tom Pope

Changing the process and mindset of health care professionals was the key to reducing emergency department overcrowding

Joseph R. Twanmoh, MD, FACEP ; Gail P. Cunningham, MD, FACEP


Legislation & Regulation
Patient advocacy groups work overtime to kill legislation that businesses felt would have provided less costly coverage for their employees
John Carroll
Medication Management
Despite the higher costs of SSRIs, compared to older antidepressants, limiting members’ access can lead to undertreated depression
Martin Sipkoff
Employer Update
Imagine an America where few businesses purchase health care for employees. Should that come about, the individual market will have new products ready.
Lola Butcher
Tomorrow’s Medicine
Although Myozyme is approved for the infantile form of Pompe disease, it is logical to extend coverage to patients with the late onset form
Thomas Morrow, MD

Our most popular topics on Managedcaremag.com